Celea Therapeutics raised $180 million in financing.
- Amount
- $180M
- Announced
- 2 July 2026
- Investors
- RA Capital Management, Leaps by Bayer, PureTech Health
- Use of funds
- Initiating the planned early Q3 2026 Phase 3 SURPASS-IPF trial of deupirfenidone.
- Checked
- Amount and date checked against the press source